- Home
- CABO vs RCKT Comparison
CABO vs RCKT Comparison
Compare CABO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CABO | RCKT |
|---|---|---|
| Founded | 1980 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.0M | 340.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CABO | RCKT |
|---|---|---|
| Price | $90.41 | $3.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $126.00 | $29.12 |
| AVG Volume (30 Days) | 139.0K | ★ 1.9M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,524,897,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $91.15 | $2.19 |
| 52 Week High | $345.39 | $11.45 |
Technical Indicators
Market Signals| Indicator | CABO | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 27.57 | 55.32 |
| Support Level | $94.40 | $3.47 |
| Resistance Level | $105.53 | $3.98 |
| Average True Range (ATR) | 5.78 | 0.22 |
| MACD | -1.89 | 0.02 |
| Stochastic Oscillator | 1.70 | 55.80 |
Price Performance
Historical ComparisonAbout CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.